The GRXCR1 gene is associated with a form of hereditary hearing loss known as deafness, autosomal recessive type 25 (DFNB25). This condition is characterized by a range of hearing impairments, from mild to profound, that are present from birth. The GRXCR1 gene plays a crucial role in the development and maintenance of hair cells within the inner ear, which are essential for normal hearing function.
At DNA Labs UAE, individuals concerned about their risk of inheriting or passing on this form of deafness can undergo a genetic test specifically designed to identify mutations in the GRXCR1 gene. The test is conducted through a simple and non-invasive procedure, typically involving a blood sample or cheek swab, which is then analyzed in the laboratory to detect any genetic anomalies associated with DFNB25.
The cost of the GRXCR1 gene deafness autosomal recessive type 25 genetic test at DNA Labs UAE is 4400 AED. This investment provides valuable insights into an individual's genetic predisposition to this form of hearing loss, enabling early intervention and informed decision-making regarding family planning. It is a critical resource for families with a history of hearing impairment, offering a path to better understand their genetic health and the potential for future generations.
The TRIOBP Gene Deafness Autosomal Recessive Type 28 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the TRIOBP gene, which are linked to a specific form of genetic hearing loss known as Autosomal Recessive Deafness Type 28 (DFNB28). This condition is characterized by the inheritance of two copies of the mutated gene, one from each parent, leading to early-onset sensorineural hearing loss, which affects the inner ear or nerve pathways to the brain.
The test is conducted through a detailed analysis of the patient's DNA, extracted from a blood sample, to search for the specific genetic alterations within the TRIOBP gene that are known to cause this type of hearing loss. It is particularly recommended for individuals with a family history of hearing impairment or parents planning to have children who may be at risk of inheriting the condition.
Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, the test offers a comprehensive approach to diagnosing this rare form of deafness. The cost of the test is set at 4400 AED, reflecting the intricate laboratory work and expert analysis required to accurately identify the genetic mutation responsible for the condition. This test not only aids in the diagnosis but also helps in the management and planning for the needs of individuals affected by Autosomal Recessive Deafness Type 28, providing essential information for families and healthcare providers.
The CLDN14 gene plays a crucial role in the proper functioning of the inner ear, and mutations in this gene can lead to deafness autosomal recessive type 29 (DFNB29), a condition characterized by early-onset, non-syndromic sensorineural hearing loss. This form of hearing loss is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
To diagnose this specific genetic cause of deafness, a genetic test focusing on the CLDN14 gene can be conducted. DNA Labs UAE offers this specialized test, providing a valuable tool for families seeking answers about their genetic predisposition to hearing loss. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, and analyzing it for mutations in the CLDN14 gene.
The cost of the CLDN14 gene deafness autosomal recessive type 29 genetic test at DNA Labs UAE is 4400 AED. This price may cover the cost of the sample collection, genetic analysis, and a comprehensive report detailing the findings. Such a test not only helps in confirming the diagnosis but also aids in family planning and understanding the risk of passing the condition to future generations.
The MYO15A gene plays a crucial role in the development and maintenance of the inner ear's structure, which is essential for proper hearing. Mutations in the MYO15A gene can lead to deafness, autosomal recessive type 3, a condition characterized by significant hearing loss from birth. This type of genetic hearing impairment is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
DNA Labs UAE offers a specialized genetic test to identify mutations in the MYO15A gene, providing crucial information for families affected by or at risk of autosomal recessive deafness type 3. The test involves analyzing the individual's DNA, extracted from a blood sample or cheek swab, to detect any alterations in the MYO15A gene that could lead to the condition.
The cost of the MYO15A gene deafness autosomal recessive type 3 genetic test at DNA Labs UAE is 4400 AED. This test is particularly valuable for prospective parents with a family history of the condition, individuals who have been diagnosed with unexplained hearing loss, and families seeking more information about their genetic health. By identifying the specific genetic cause of deafness, the test can facilitate informed decisions about family planning, early intervention, and management strategies for affected individuals.
The MYO3A Gene Deafness Autosomal Recessive Type 30 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MYO3A gene that are linked to a form of hereditary hearing loss. This condition, known as Autosomal Recessive Deafness Type 30 (DFNB30), is characterized by the inheritance of two defective copies of the MYO3A gene, one from each parent, leading to early-onset hearing impairment. The test is crucial for families with a history of this condition, as it provides vital information for making informed decisions about management and intervention strategies.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations associated with DFNB30. The process is highly accurate and can pinpoint the genetic alterations responsible for the condition, offering insights into the likelihood of passing the mutation to future generations. Given the autosomal recessive inheritance pattern, understanding one's carrier status is particularly important for family planning purposes.
DNA Labs UAE, known for its state-of-the-art genetic testing services, ensures confidentiality and provides comprehensive support throughout the testing process. The results from this test not only aid in confirming a diagnosis but also play a critical role in guiding audiologists and other healthcare professionals in tailoring the most appropriate intervention and support for individuals affected by this form of genetic hearing loss.
The WHRN gene, also known as whirlin, is linked to a type of hearing loss known as Deafness Autosomal Recessive Type 31 (DFNB31). This genetic condition is characterized by the mutation in the WHRN gene, which plays a crucial role in the development and maintenance of the inner ear's structure and function. Individuals with mutations in this gene typically experience prelingual, non-syndromic sensorineural hearing loss, meaning the hearing loss occurs before speech development and is not associated with other symptoms.
To diagnose this specific genetic form of deafness, a genetic test is available at DNA Labs UAE. The test specifically looks for mutations in the WHRN gene that are known to cause DFNB31. It involves collecting a DNA sample, usually through a blood draw or a cheek swab, and then analyzing the genetic material for the presence of mutations.
The cost of the WHRN Gene Deafness Autosomal Recessive Type 31 Genetic Test at DNA Labs UAE is 4400 AED. This test is crucial for families with a history of this type of hearing loss, as it can provide a definitive diagnosis, guide treatment options, and offer information on the risk of passing the condition to future generations.
The ESRRB Gene Deafness Autosomal Recessive Type 35 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the ESRRB gene that are responsible for Autosomal Recessive Deafness Type 35 (DFNB35). This condition is characterized by non-syndromic sensorineural hearing loss, which means it affects the inner ear or the nerve pathways to the brain without affecting other parts of the body. The test is crucial for families with a history of this condition, as it can provide definitive diagnosis, inform treatment decisions, and guide family planning.
Conducted through a sample of blood or saliva, the test specifically looks for alterations in the ESRRB gene, which plays a significant role in the development and maintenance of inner ear structures essential for hearing. Identifying a mutation can help in understanding the cause of deafness in an individual or family, facilitating early intervention and management strategies.
The cost of the ESRRB Gene Deafness Autosomal Recessive Type 35 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately detect and interpret genetic mutations associated with this form of hearing loss.
The "ESPN Gene Deafness Autosomal Recessive Type 36 Genetic Test" is a specific diagnostic tool designed to detect mutations in the ESPN gene, which can lead to autosomal recessive nonsyndromic deafness 36 (DFNB36). This condition is characterized by hearing loss that does not present with other symptoms. The test is crucial for early detection, allowing for timely intervention and management strategies to improve the quality of life for affected individuals.
Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the test involves analyzing the patient's DNA to identify any alterations in the ESPN gene. These mutations disrupt the normal function of the protein produced by the gene, leading to the development of hearing loss.
The cost of the test is set at 4400 AED, reflecting the intricate process of genetic analysis and the specialized expertise required to interpret the results. By offering this test, DNA Labs UAE provides a vital resource for families with a history of hearing loss, enabling them to make informed decisions about their health and future.
The "HGF Gene Deafness Autosomal Recessive Type 39 Genetic Test" is a specialized diagnostic assessment designed to identify mutations in the HGF gene, which are linked to Autosomal Recessive Type 39 Deafness. This condition is a form of genetic hearing loss where an individual must inherit two copies of the altered gene, one from each parent, to be affected. The test is crucial for early detection and management of the condition, allowing for tailored interventions and support.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test provides a comprehensive analysis of the HGF gene to detect any abnormalities that could lead to hearing loss. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify mutations in the gene. By opting for this test, individuals at risk can gain valuable insights into their genetic makeup, enabling informed decisions about their health and preventive measures to mitigate the impact of the condition.
The FOXI1 Gene Deafness Autosomal Recessive Type 4 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the FOXI1 gene, which are linked to a specific form of hereditary hearing loss. This type of hearing impairment, known as Autosomal Recessive Deafness Type 4, is passed down through families in a manner where both parents must carry a copy of the mutated gene to pass the condition onto their children. The test is crucial for early detection and management of the condition, allowing healthcare professionals to provide appropriate interventions and support to affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to identify any mutations in the FOXI1 gene that are associated with this type of deafness. The results can offer valuable information regarding the genetic predisposition of an individual to develop this condition, facilitating informed decisions about family planning and management strategies for those already affected.
The cost of the FOXI1 Gene Deafness Autosomal Recessive Type 4 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, covering the expenses associated with the sophisticated technology and expertise required to accurately detect and interpret genetic mutations. For families and individuals facing the possibility of Autosomal Recessive Deafness Type 4, this test represents a critical step towards understanding and managing the condition effectively.
